News

BizWest unveils finalists for IQ Awards

October 17, 2017

We’re excited to announce that Front Range Biosciences has been chosen as a finalist for the 2017 BizWest Innovation Quotient (IQ) Award! We’re in prestigious company, alongside the two other finalists of SomaLogic and Array BioPharma in the Life Sciences category. View BizWest’s summary of FRB below:

"Front Range Biosciences — Through the process of tissue culture cloning, FRB solves the various operational problems that cultivators currently face, such as disease, inefficiency, inconsistency and scale. Tissue culture is sterile propagation of baby plants through cloning on a nutrient culture medium of known composition. Plant tissue culture is widely used to produce clones of a plant in a method known as micropropagation. Additionally, FRB’s varietal improvement program, using Next Generation Sequencing technology to create a map of cannabis genetics, helps develop commercially relevant traits in cannabis plants."

See the full announcement on BizWest here.


ADDITIONAL INFORMATION:
  • Searching for cannabinoid-rich hemp plants? To view our current availability for cannabinoid-rich clones from our Clean Stock® program, as well as our seedlings and feminized seeds, contact our sales team at: sales@frontrangebio.com or complete an order inquiry at: https://www.frontrangebio.com/inquire
  • Stay up-to-date with FRB’s current events and information by following our Resources page